Scleroderma Pseudo-tumors Assessment

Scleroderma Assessment Tool - Evaluate Systemic Sclerosis Features

The Scleroderma Assessment Tool is a comprehensive clinical evaluation instrument designed to assess the extent and severity of systemic sclerosis (scleroderma), including detection of pseudo-tumor formations and other disease manifestations. Systemic sclerosis is a complex autoimmune connective tissue disorder characterized by skin thickening, vascular abnormalities, and internal organ fibrosis affecting the lungs, heart, kidneys, and gastrointestinal tract. Scleroderma pseudo-tumors represent localized areas of extensive calcinosis or fibrotic tissue deposits that may mimic neoplastic masses on physical examination or imaging. This assessment tool helps rheumatologists and other specialists systematically evaluate skin involvement using modified Rodnan skin score, assess vascular complications including digital ulcers and Raynaud's phenomenon severity, monitor internal organ involvement, and identify pseudo-tumors that may require biopsy or specialized imaging. Early recognition of systemic sclerosis and accurate assessment of disease extent are crucial for initiating appropriate immunosuppressive therapy, preventing irreversible organ damage, and improving long-term outcomes. The tool incorporates evaluation of pulmonary function, cardiac involvement, renal crisis risk factors, and gastrointestinal dysmotility—all of which significantly impact prognosis and treatment decisions. Regular systematic assessment helps track disease progression, guide therapy intensification, and identify complications requiring specific interventions.